Infectious Disease
Helicobacter Pylori Eradication
0
Pipeline Programs↗
14
Active Trials↗
3
Companies Involved↗
Helicobacter Pylori Eradication is an early-stage landscape with 0 programs across 3 companies. The most active players are Hangzhou Grand Biologic Pharmaceutical, Inc., Takeda, TenNor Therapeutics (Suzhou) Limited.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
76
clinical trials
Completed47 · 62%
Unknown status13 · 17%
Recruiting9 · 12%
Not yet recruiting4 · 5%
Enrolling by invitation1 · 1%
Suspended1 · 1%
Other1 · 1%
Clinical Trials
Trial Activity
76 trials
A "Screen and Treat" Helicobacter Pylori Eradication Trial in Adolescents in Three Regions of Chile
Recruiting·—·N/A·NCT05926804·500 enrolled
Efficacy Comparison of Vonoprazan Combined With Different Antibiotics in Dual Therapy for Helicobacter Pylori Eradication: A Prospective, Randomized Controlled Clinical Trial
Recruiting·—·Phase 4·NCT07068607·400 enrolled
Vonoprazan Evaluation Compared to Standard Triple Therapy in Helicobacter Pylori eRadication
Recruiting·—·Phase 4·NCT06959368·484 enrolled
CURE-H. Pylori: A Trial on the Combination of Anti-Ulcerants and Levofloxacin-Based Therapy for Helicobacter Pylori Eradication
Recruiting·—·Phase 4·NCT07344506·942 enrolled
The Efficacy and Safety of Keverprazan for Helicobacter Pylori Eradication
Not yet recruiting·NNanjing First Hospital, Nanjing Medical University·Phase 1·NCT06777732·672 enrolled
Page 1 of 6
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)